I am an investor

I want to know more about Cantargia's research

I want to know more about Cantargia as a company

Presentation at ASCO 2019, follow up articles and interviews

Cantargia interview at EFN after ASCO

To the interview (in Swedish)

Cantargia partners up with pioneer within biotech industry

A brief introduction to Cantargia

To the interview

Two Nobel Prizes with utmost significance for Cantargia’s research

Press releases

2020-05-27 (R) Annual General Meeting in Cantargia AB (publ)

2020-05-27 (R) Cantargia publishes interim report for first quarter 2020

2020-05-15 (R) Cantargia presents new preclinical data on CAN04 in combination with chemotherapy at the 2020 AACR Annual Meeting

(R) = Regulatory press releases

”During 2018, we concluded the first very important part of the clinical development of CAN04 and presented patient data that strengthens our hopes that CAN04 can become an important part of tomorrow’s cancer treatment”

Göran Forsberg

CEO Cantargia

Analysis

2020-05-06, Edison analysis of Cantargia

2020-02-28, Nordea analysis of Cantargia

Redeye analysis of Cantargia (in Swedish)

2019-12-17, Edison analysis of Cantargia

Presentations